Accordingly, our research findings suggest that the elevation of CA and reduction of UDCA levels in circulating serum activate FXR expression, thereby modulating the FXR/FGF15 pathway, affecting BAs synthesis, and improving T2DM. Here, NR1H4 is linked to type 2 diabetes mellitus.